Innova Captab Limited has informed the Exchange regarding 'Mr. Devendra Ganpatrav Palav, who currently serves as the Chief Executive Officer (CEO) of Sharon Bio-Medicine Limited, a material subsidiary of the Company, has been redesignated as Manager, in addition to his existing role as CEO'.
INNOVACAP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Innova Captab Limited has informed the stock exchange about a change in the role of Mr. Devendra Ganpatrav Palav at its material subsidiary, Sharon Bio-Medicine Limited. Mr. Palav, who was serving as the Chief Executive Officer (CEO) of Sharon Bio-Medicine, has now been redesignated as Manager, while continuing in his existing role as CEO. This means he will hold both titles simultaneously. No other leadership changes were disclosed in this filing.
This is an internal administrative redesignation at a subsidiary level and is unlikely to have any material impact on Innova Captab's stock price or shareholder value, as the individual continues in his existing capacity with an additional designation.